Duchenne

Pharma

Lawmakers pressure PTC on Emflaza price

When PTC agreed to buy Marathon's Emflaza last week, it inherited congressional scrutiny on the drug's price, originally set at a much-lambasted $89,000.

Eric Sagonowsky Mar 23, 2017 9:08am

Marathon makes surprise deal to sell Emflaza for $140M-plus

Mar 16, 2017 10:40am

Lawmakers pull FDA into the dock over Marathon's Emflaza nod

Mar 15, 2017 4:51pm

Eight senators pile on to Marathon's $89K Emflaza price tag

Mar 6, 2017 10:30am

Marathon halts launch of DMD drug as $89K price attracts congressional heat

Feb 13, 2017 4:56pm